Genten Therapeutics
About:
Genten Therapeutics is a provider a monotherapy through an antigen specific induction.
Description:
Genten Therapeutics develops a monotherapy through an antigen specific induction of immune tolerance for gluten. The company was incorporated in 2016 and is based in San Francisco, California.
Total Funding Amount:
$12M
Headquarters Location:
San Francisco, California, United States
Founded Date:
2016-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2016-10-03
IPO Status:
Private
Industries:
© 2025 bioDAO.ai